<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mitsueda R</submitter><funding>KAKENHI</funding><funding>Naoko Kikkawa</funding><funding>Mayuko Kato</funding><funding>Naohiko Seki</funding><funding>Hiroko Toda</funding><funding>Yoshiaki Shinden</funding><pagination>4189</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10453418</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(16)</volume><pubmed_abstract>Accumulating evidence suggests that the &lt;i>miR-30&lt;/i> family act as critical players (tumor-suppressor or oncogenic) in a wide range of human cancers. Analysis of microRNA (miRNA) expression signatures and The Cancer Genome Atlas (TCGA) database revealed that that two passenger strand miRNAs, &lt;i>miR-30c-1-3p&lt;/i> and &lt;i>miR-30c-2-3p&lt;/i>, were downregulated in cancer tissues, and their low expression was closely associated with worse prognosis in patients with BrCa. Functional assays showed that &lt;i>miR-30c-1-3p&lt;/i> and &lt;i>miR-30c-2-3p&lt;/i> overexpression significantly inhibited cancer cell aggressiveness, suggesting these two miRNAs acted as tumor-suppressors in BrCa cells. Notably, involvement of passenger strands of miRNAs is a new concept of cancer research. Further analyses showed that se</pubmed_abstract><journal>Cancers</journal><pubmed_title>Oncogenic Targets Regulated by Tumor-Suppressive &lt;i>miR-30c-1-3p&lt;/i> and &lt;i>miR-30c-2-3p&lt;/i>: &lt;i>TRIP13&lt;/i> Facilitates Cancer Cell Aggressiveness in Breast Cancer.</pubmed_title><pmcid>PMC10453418</pmcid><funding_grant_id>22K08705</funding_grant_id><funding_grant_id>21K09577</funding_grant_id><funding_grant_id>22K09679</funding_grant_id><funding_grant_id>21K09367</funding_grant_id><funding_grant_id>23K08094</funding_grant_id><pubmed_authors>Fukuda K</pubmed_authors><pubmed_authors>Toda H</pubmed_authors><pubmed_authors>Shinden Y</pubmed_authors><pubmed_authors>Yasudome R</pubmed_authors><pubmed_authors>Kato M</pubmed_authors><pubmed_authors>Mitsueda R</pubmed_authors><pubmed_authors>Nakajo A</pubmed_authors><pubmed_authors>Kikkawa N</pubmed_authors><pubmed_authors>Ohtsuka T</pubmed_authors><pubmed_authors>Seki N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Oncogenic Targets Regulated by Tumor-Suppressive &lt;i>miR-30c-1-3p&lt;/i> and &lt;i>miR-30c-2-3p&lt;/i>: &lt;i>TRIP13&lt;/i> Facilitates Cancer Cell Aggressiveness in Breast Cancer.</name><description>Accumulating evidence suggests that the &lt;i>miR-30&lt;/i> family act as critical players (tumor-suppressor or oncogenic) in a wide range of human cancers. Analysis of microRNA (miRNA) expression signatures and The Cancer Genome Atlas (TCGA) database revealed that that two passenger strand miRNAs, &lt;i>miR-30c-1-3p&lt;/i> and &lt;i>miR-30c-2-3p&lt;/i>, were downregulated in cancer tissues, and their low expression was closely associated with worse prognosis in patients with BrCa. Functional assays showed that &lt;i>miR-30c-1-3p&lt;/i> and &lt;i>miR-30c-2-3p&lt;/i> overexpression significantly inhibited cancer cell aggressiveness, suggesting these two miRNAs acted as tumor-suppressors in BrCa cells. Notably, involvement of passenger strands of miRNAs is a new concept of cancer research. Further analyses showed that se</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2026-06-23T03:13:05.058Z</modification><creation>2025-04-07T10:19:10.405Z</creation></dates><accession>S-EPMC10453418</accession><cross_references><pubmed>37627217</pubmed><doi>10.3390/cancers15164189</doi></cross_references></HashMap>